PDCD1LG2 and rheumatoid arthritis: To explain the down-modulation of PD-1 pathway in RA pathogenesis and disease progression, we examined the possibility that elevated serum sPD-1 levels might interfere with the normal PD1-PDL1 signaling by sheer competition for the cell surface PD-L1/PD-L2.